Twinkle, twinkle farthest star ⭐ Hubble just smashed records by observing the farthest individual star ever seen. Its light took 12.9 billion years to reach us—so we're seeing how it looked when the universe was less than a billion years old! More: go.nasa.gov/3wMrHDp

This was a huge team effort! Led by a fantastic scientist Dr. Avani Vyas co-mentored by Dr. Kirill Kiselyov (Dept of Biology University of Pittsburgh ). This was exhausting, but fun multidisciplinary project. Couldn’t have done it without @drmagpie1 ! Pitt Oto Pitt Head & Neck Surgery

Congratulations to our 2022 Graduates! The day was spent showcasing and celebrating all they have achieved over the years and a special serenade to end the night! 🎶It's something unpredictable But in the end, it's right I hope you had the time of your life 🎶

Only by embracing uncertainty can we shed our fears and reach our true potential. #ThursdayThoughts

Goal of neoadjuvant immunotherapy must be pCR and this is most likely in tumors with moderate to high PDL1 expression. This is what we should focus on. aacrjournals.org/clincancerres/…

Paper is finally out in Nature Genetics! "Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment" Check out our catalog of conserved cancer cell states defined by scRNA-Seq & ST. Congrats @BarkleyDalia! nature.com/articles/s4158…

So proud of the gang from #DuvvuriLab for a great showing at #ENASymp22 Abdul Kassab & #AvaniVyas (not on Twitter) did a lot of work. This would be possible with a Herculean lift from Silvia Cruz & numerous residents/ fellows. Marco R. Alex Harbison, MD MS Schmitt Lab

Fantastic work, team! Abdul Kassab, future OtoHNS resident and great addition to any team, great work with the polyamine transport inhibition and cisplatin combined therapy. Impressive response in MOC2 allografts!

Very exciting and important work!

Big news for the Duvvuri-Nance’s. I will serve as Chair of Oto:HNS NYU Grossman School of Medicine Dr. Nance will serve as Assoc Prof & Chief at VANYHHC & lead some DEI efforts at NYU. We will miss PGH, friends & pts. It has been an honor to serve this wonderful community. UPMC

Guangyong Peng, MD, PhD, has received a new R01 from NIH for his study, Excessive lipid metabolism in T cell senescence and immunosuppression. Total amount of the five-year award is $1.94 million. This is Peng’s fourth active R01. Please join us in congratulating Dr. Peng!

If you think physicians are overpaid, maybe you should take the necessary course work in undergrad, take and pass the MCAT, apply for med schools, pay hundreds of thousands for tuition, learn for 4 years in a very high pressure learning environment, then pay thousands more to

JCI - Immunotherapeutic strategies in head and neck cancer: challenges and opportunities jci.org/articles/view/… Team effort with Drs. Liu, Sid Puram, MD PhD (Puram Lab), Peng, and Varvares to update the past, present, and future of immunotherapy in head and neck cancer.